Telephone Whatsapp
NABH Accredited NABL Accredited ISO Certified
NABH Accredited NABL Accredited ISO Certified
img

UGT1A1 GENE POLYMORPHISM (NUCLEOTIDE TA REPEATS) DETECTION -Delhi

OUTSOURCE

UGT1A1 GENE POLYMORPHISM (NUCLEOTIDE TA REPEATS) DETECTION

Also Known As: UGT1A1 UGT1A1 Gene Polymorphism (Irinotecan Dosage)

About This Test

Genetic variants in UGT1A1 may cause reduced or absent UGT1A1 enzymatic activity, resulting in conditions associated with unconjugated hyperbilirubinemia including Gilbert syndrome and Crigler-Najjar syndromes types I and II. Gilbert syndrome is the most common hereditary cause of increased bilirubin. This assay also helps in identifying individuals who are at increased risk of adverse reactions with drugs that are metabolized by UGT1A1 including Irinotecan, Atazanavir, Nilotinib, Pazopanib and Belinostat.

Test Parameters (1)

  • UGT1A1 GENE POLYMORPHISM (NUCLEOTIDE TA REPEATS) DETECTION
Home Collection
✓ Available
Reports Available In
1 Day

Preparation / Prerequisite

4 ML (2 ML Min.) Whole Blood In 1 Lavender Top (EDTA) Tube. Ship Refrigerated. DO NOT FREEZE.

Frequently Asked Questions

Outsourced test are being done from Dr. Lal Path Lab. Charges and reporting time is same as of Dr. Lal Path Labs.

No special preparation required

The UGT1A1 test is important because it helps identify inherited and drug-related disorders of bilirubin metabolism, guides safe medication use, and prevents serious drug toxicity, especially in oncology and antiviral therapy.

TAT Policy

The Turnaround Time (TAT) depends on the following factors:

  • Registration date and time
  • Type of scan or test
  • Scan time or sample collection time

In uncommon circumstances, TAT may be delayed due to test complexity or reasons beyond our control. You will be informed of the estimated TAT at the time of registration.

₹5,810
Home Collection
✓ Available
Reports Available In
1 Day
Get a Call Back Book Now

Have a query or suggestion for us? Feel free to drop us a message and we'll get back to you as soon as possible.